Diminazene Aceturate, an angiotensin converting enzyme 2 (ACE2) activator, promotes cardioprotection in ischemia/reperfusion-induced cardiac injury
Sign Up to like & getrecommendations! Published in 2022 at "Peptides"
DOI: 10.1016/j.peptides.2022.170746
Abstract: This study aimed to investigate whether the Diminazene Aceturate (DIZE), an angiotensin-converting enzyme 2 (ACE2) activator, can revert cardiac dysfunction in ischemia reperfusion-induced (I/R) injury in animals and examine the mechanism underlying this effect. Wistar… read more here.
Keywords: injury; diminazene aceturate; enzyme ace2; angiotensin converting ... See more keywords
Coronavirus disease 2019 (COVID-19) and the renin-angiotensin system: A closer look at angiotensin-converting enzyme 2 (ACE2)
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Clinical Biochemistry"
DOI: 10.1177/0004563220928361
Abstract: Since the first cases of atypical pneumonia linked to the Huanan Seafood Wholesale Market in Wuhan, China, were described in late December 2019, the global landscape has changed radically. In March 2020, the World Health… read more here.
Keywords: converting enzyme; angiotensin converting; coronavirus; covid ... See more keywords
Is targeting angiotensin-converting enzyme 2 (ACE2) a prophylactic strategy against COVID-19?
Sign Up to like & getrecommendations! Published in 2022 at "Bioscience trends"
DOI: 10.5582/bst.2022.01524
Abstract: Prophylaxis against COVID-19 is greatly needed for vulnerable populations who have a higher risk of developing severe disease. Vaccines and neutralizing antibodies against SARS-CoV-2 are currently the main approaches to preventing the virus infection. However,… read more here.
Keywords: converting enzyme; covid; sars cov; enzyme ace2 ... See more keywords